Evaluation of the Incidence of Hematologic Malignant Neoplasms Among Breast Cancer Survivors in France

por Jabagi, Marie Joelle, Vey, Norbert, Goncalves, Anthony, Le Tri, Thien, Zureik, Mahmoud, Dray-Spira, Rosemary
Publicado 2019

Risk of Hematologic Malignant Neoplasms after Postoperative Treatment of Breast Cancer

por Jabagi, Marie Joelle, Goncalves, Anthony, Vey, Norbert, Le Tri, Thien, Zureik, Mahmoud, Dray-Spira, Rosemary
Publicado 2019

Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations

por Botton, Jérémie, Semenzato, Laura, Jabagi, Marie-Joëlle, Baricault, Bérangère, Weill, Alain, Dray-Spira, Rosemary, Zureik, Mahmoud
Publicado 2022

Stroke, Myocardial Infarction, and Pulmonary Embolism after Bivalent Booster

por Jabagi, Marie-Joelle, Bertrand, Marion, Botton, Jérémie, Le Vu, Stéphane, Weill, Alain, Dray-Spira, Rosemary, Zureik, Mahmoud
Publicado 2023

Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines

por Botton, Jérémie, Dray-Spira, Rosemary, Baricault, Bérangère, Drouin, Jérôme, Bertrand, Marion, Jabagi, Marie-Joëlle, Weill, Alain, Zureik, Mahmoud
Publicado 2022

Protection of COVID-19 Vaccination Against Hospitalization During the Era of Omicron BA.4 and BA.5 Predominance: A Nationwide Case–Control Study Based on the French National Health...

por Semenzato, Laura, Botton, Jérémie, Le Vu, Stéphane, Jabagi, Marie-Joëlle, Cuenot, François, Drouin, Jérôme, Dray-Spira, Rosemary, Weill, Alain, Zureik, Mahmoud
Publicado 2023

Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines

por Le Vu, Stéphane, Bertrand, Marion, Jabagi, Marie-Joelle, Botton, Jérémie, Drouin, Jérôme, Baricault, Bérangère, Weill, Alain, Dray-Spira, Rosemary, Zureik, Mahmoud
Publicado 2022

A modified self‐controlled case series method for event‐dependent exposures and high event‐related mortality, with application to COVID‐19 vaccine safety

por Ghebremichael‐Weldeselassie, Yonas, Jabagi, Marie Joëlle, Botton, Jérémie, Bertrand, Marion, Baricault, Bérangère, Drouin, Jérôme, Weill, Alain, Zureik, Mahmoud, Dray‐Spira, Rosemary, Farrington, Paddy
Publicado 2022

Characteristics associated with the residual risk of severe COVID-19 after a complete vaccination schedule: A cohort study of 28 million people in France

por Semenzato, Laura, Botton, Jérémie, Drouin, Jérôme, Baricault, Bérangère, Bertrand, Marion, Jabagi, Marie-Joëlle, Cuenot, François, Vu, Stéphane Le, Dray-Spira, Rosemary, Weill, Alain, Zureik, Mahmoud
Publicado 2022

Effectiveness of BNT162b2, mRNA-1273, and ChAdOx1-S vaccines against severe covid-19 outcomes in a nationwide mass vaccination setting: cohort study

por Bouillon, Kim, Baricault, Bérangère, Botton, Jérémie, Jabagi, Marie-Joëlle, Bertrand, Marion, Semenzato, Laura, Le Vu, Stéphane, Drouin, Jérôme, Dray-Spira, Rosemary, Weill, Alain, Zureik, Mahmoud
Publicado 2022